Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial-Reference-Cited by-同舟云学术

Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial

Published:2019-01 Issue:10167 Volume:393 Page:133-142
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Näslund Ulf,Ng Nawi,Lundgren Anna,Fhärm Eva,Grönlund Christer,Johansson Helene,Lindahl Bernt,Lindahl Bertil,Lindvall Kristina,Nilsson Stefan K,Nordin Maria,Nordin Steven,Nyman Emma,Rocklöv Joacim,Vanoli Davide,Weinehall Lars,Wennberg Patrik,Wester Per,Norberg Margareta

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes;Kones;Vasc Health Risk Manag,2013

2. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions

3. General cardiovascular risk profile for use in primary care: the Framingham Heart Study;D'Agostino;Circulation,2008

4. 2016 European Guidelines on cardiovascular disease prevention in clinical practice

5. Global cardiovascular risk assessment in the primary prevention of cardiovascular disease in adults: systematic review of systematic reviews;Collins;BMJ Open,2017

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension;European Heart Journal;2024-08-30

2. Dose-Dependent association of cumulative tobacco consumption with the presence of carotid atherosclerosis in individuals with type 1 diabetes;Diabetes Research and Clinical Practice;2024-08

3. Evaluation of Cardiovascular Risk in People with Type 1 Diabetes: A Comprehensive and Specific Proposed Practical Approach;Diabetes Therapy;2024-07-08

4. Arterial stiffness in subclinical atherosclerosis quantified with ultrafast pulse wave velocity measurements: a comparison with a healthy population using propensity score matching;Ultrasonography;2024-07-01

5. Poor Results with “Best Medical Therapy” in Patients with Asymptomatic Carotid Stenosis;Annals of Vascular Surgery;2024-06